Gazit America Inc. announces resignation of its CFO

/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/

TORONTO, April 15 /CNW/ - Gazit America Inc. (the "Company") (TSX: GAA) today announced that David Dinniwell, the Company's Chief Financial Officer, has decided to resign for personal reasons. Mr. Dinniwell has agreed that his resignation will be effective May 13, 2010, after the release of the Company's financial statements for the quarter ended March 31, 2010.

Gail Mifsud, Chief Executive Officer of the Company said, "David joined the Company at its IPO and played a significant role in our establishment as a stand-alone public company. We are grateful for his efforts and wish him well in his future endeavours."

ABOUT GAZIT AMERICA (TSX: GAA)

Gazit America is focused on entrepreneurial real estate investments including the acquisition and development of income-producing properties, investments in public and private real estate entities, investments in joint ventures and other structured acquisitions and investments in commercial and residential mortgage-backed securities. Gazit America currently owns approximately 15.5% of Equity One, Inc. (NYSE: EQY), a U.S. real estate investment trust, and three properties comprised of six medical office buildings totalling approximately 164,000 square feet of rentable space located in Cambridge, London and Ottawa, Ontario.

SOURCE Gazit America Inc.

For further information: For further information: regarding Gazit America: Gail Mifsud, C.E.O., Gazit America Inc., 109 Atlantic Avenue, Suite 303, Toronto, Ontario, Canada, M6K 1X4, Tel: (416) 447-6400, Fax: (416) 447-6488, www.gazitamerica.com

Organization Profile

Gazit America Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890